tiprankstipranks
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market
Holding NVCT?
Track your performance easily

Nuvectis Pharma (NVCT) Technical Analysis

82 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Nuvectis Pharma’s (NVCT) Moving Averages Convergence Divergence (MACD) indicator is -0.37, suggesting Nuvectis Pharma is a Buy.
Nuvectis Pharma’s (NVCT) 20-Day exponential moving average is 7.21, while Nuvectis Pharma’s (NVCT) share price is $4.9, making it a Sell.
Nuvectis Pharma’s (NVCT) 50-Day exponential moving average is 7.17, while Nuvectis Pharma’s (NVCT) share price is $4.9, making it a Sell.

Nuvectis Pharma (NVCT) Pivot Points

Nov 22, 2024, 06:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.02
4.39
4.76
5.13
5.50
5.87
6.24
Fibonacci
4.39
4.67
4.84
5.13
5.41
5.58
5.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Nuvectis Pharma (NVCT) Moving Averages

Nov 22, 2024, 06:09 PM
Period
Simple
Exponential
MA5
5.19Sell
5.79Sell
MA10
7.75Sell
6.70Sell
MA20
7.72Sell
7.21Sell
MA50
7.04Sell
7.17Sell
MA100
6.83Sell
7.05Sell
MA200
7.17Sell
7.32Sell
Nuvectis Pharma’s (NVCT) 10-Day exponential moving average is 6.70, while Nuvectis Pharma’s (NVCT) share price is $4.9, making it a Sell.
Nuvectis Pharma’s (NVCT) 100-Day exponential moving average is 7.05, while Nuvectis Pharma’s (NVCT) share price is $4.9, making it a Sell.
Nuvectis Pharma’s (NVCT) stock price is $4.9 and Nuvectis Pharma’s (NVCT) 50-day simple moving average is 7.04, creating a Sell signal.
Nuvectis Pharma’s (NVCT) stock price is $4.9 and Nuvectis Pharma’s (NVCT) 100-day simple moving average is 6.83, creating a Sell signal.
Nuvectis Pharma’s (NVCT) stock price is $4.9 and Nuvectis Pharma’s (NVCT) 200-day simple moving average is 7.17, creating a Sell signal.

Nuvectis Pharma (NVCT) Technical Indicators

Nov 22, 2024, 06:09 PM
Name
Value
Implied Action
RSI (14)
36.46
Neutral
STOCH (9,6)
4.41
Buy
STOCHRSI (14)
4.41
Buy
MACD (12,26)
-0.37
Buy
ADX (14)
27.19
Neutral
Williams %R
-95.46
Buy
CCI (14)
-114.92
Buy
ATR (14)
1.18
-
Ultimate Oscillator
36.76
Neutral
ROC
-32.13
Sell
Nuvectis Pharma’s (NVCT) Relative Strength Index (RSI) is 36.46, creating a Neutral signal.
Nuvectis Pharma’s (NVCT) Trend Strength Indicator (ADX) is 27.19, creating a Neutral signal.
Nuvectis Pharma’s (NVCT) Commodity Channel Index (CCI) is -114.92, creating a Buy signal.
Nuvectis Pharma’s (NVCT) Price Rate of Change (ROC) is -32.13, creating a Sell signal.

FAQ

Is NVCT a Buy, Hold, or Sell?
Based on NVCT’s technical indicators, NVCT is a Sell.
    What is NVCT’s RSI (14)?
    NVCT’s RSI (14) is 36.46, which suggests NVCT is a Neutral.
      What is NVCT’s MACD?
      NVCT’s MACD is -0.37, which suggests NVCT is a Buy.
        What is NVCT’s 5-day moving average?
        NVCT’s 5-day moving average is 5.19, which suggests NVCT is a Sell.
          What is NVCT’s 20-day moving average?
          NVCT 20-day moving average is 7.72, which suggests NVCT is a Sell.
            What is NVCT’s 50-day moving average?
            NVCT’s 50-day moving average is 7.04, which suggests NVCT is a Sell.
              What is NVCT’s 200-day moving average?
              NVCT’s 200-day moving average is 7.17, which suggests NVCT is a Sell.
                What is NVCT’s Williams % R (14)?
                NVCT’s Williams % R (14) is -95.46, which suggests NVCT is a Buy.
                  What is NVCT’s CCI (14)?
                  NVCT’s CCI (14) is -114.92, which suggests NVCT is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis